The team’s work will emphasize the role of specialized MRI techniques capable of detecting subtle changes around tumors with the help of pH-based imaging.
Using a virtual reality headset, the system, dubbed AR-VIU (augmented real-time volumetric imaging in ultrasound), creates a 3D rendering of anatomy based on 2D ultrasound images.
Howard C. Herrmann, MD, principal investigator of the SMART trial, discussed his team's research on self-expanding vs. balloon-expandable TAVR valves in patients with small annuli.